SARS-CoV-2-IN-8
SARS-CoV-2-IN-8 is a SARS-CoV-2 main protease inhibitor with an IC50 value of 0.75 μM.
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C(N(C1)CC(C(O)C1(C)C2)(C)CN2C(C3=NN(C)C4=C3CCC5=C4C=CC=C5)=O)C6=NN(C)C7=C6CCC8=C7C=CC=C8
Molecular Formula
C35H38N6O3
Molecular Weight
590.71
References & Citations
[1]Shcherbakov D, et al. Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors. ACS Med. Chem. Lett. 2021.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1753406 1.0 µg DNA
PTMAP7 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 127217-APC 100 µL
GC1qR (Complement Component 1 Q Subcomponent-binding Protein Mitochondrial, Glycoprotein gC1qBP, C1qBP, GC1q-R Protein, GC1QBP, Hyaluronan-binding Protein 1, HABP1, Mitochondrial Matrix Protein p32, p33, SF2P32) (APC)
Sign In for Pricing
View Details